JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sestini, S.
Right arrow Articles by Pupi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sestini, S.
Right arrow Articles by Pupi, A.
Journal of Nuclear Medicine Vol. 46 No. 9 1444-1454
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Brain Networks Underlying the Clinical Effects of Long-Term Subthalamic Stimulation for Parkinson’s Disease: A 4-Year Follow-up Study with rCBF SPECT

Stelvio Sestini, MD, PhD1,2, Silvia Ramat, MD3, Andreas R. Formiconi, PhD1, Franco Ammannati, MD3, Sandro Sorbi, MD3 and Alberto Pupi, MD1

1 Nuclear Medicine Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
2 Nuclear Medicine Unit, Department of Diagnostic Imaging, Ospedale Misericordia e Dolce, Prato, Italy
3 Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy

The motor improvement derived from high-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson’s disease (PD) is maintained over time after surgery. The aim of the present prospective follow-up study was to assess regional cerebral blood flow (rCBF) changes related to such improvement in the long term. Methods: Ten PD patients with STN-DBS underwent 3 rCBF SPECT studies at rest—once preoperatively in the off-drug condition and the other 2 postoperatively in the off-drug/on-stimulation conditions at 5 ± 2 and 42 ± 7 mo. Patients were administered with Unified Parkinson Disease Rating Scale (UPDRS), Hoehn and Yahr (H&Y) scale, and Schwab and England (S&E) scale. Statistical parametric mapping was used to investigate rCBF changes during long-term STN stimulation in comparison with preoperative rCBF and the relationship between rCBF and UPDRS scores was used as a covariate of interest. Results: All patients showed a maximum clinical improvement during the first months after surgery and remained rather stable during further follow-up. The effect of STN-DBS from the pre- to the postoperative condition at 5 mo was to produce rCBF increases in the presupplementary motor area (pre-SMA), premotor (PMC), and dorsolateral prefrontal cortices. From the postoperative condition at 5 mo to that at 42 mo, the STN stimulation produced further rCBF increases in these frontal areas, and also in the primary motor/sensory cortices, globus pallidi, ventral lateral thalamic nuclei, cerebellum, pons, and midbrain entailing the substantia nigra (P < 0.0001). A correlation was detected between the improvement in motor scores and the rCBF increase in the pre-SMA and PMC (P < 0.0001). No correlation was present between the daily consumption of levodopa and the rCBF. Conclusion: Our study suggests that the long-term STN stimulation leads to improvement in neural activity in the frontal motor/associative areas. After an rCBF increase during the first months of stimulation, these regions showed a further increment in the later phase, which was accompanied by an increased activity in subcortical structures. The correlation between motor improvement and rCBF increase in higher order motor cortical areas suggests that even in the long term, as well as in the short term, the STN-DBS achieves its therapeutic benefit by restoring the activity within these cortical regions.

Key Words: Parkinson’s disease • deep brain stimulation • subthalamic nucleus • SPECT


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
BrainHome page
M. Karimi, N. Golchin, S. D. Tabbal, T. Hershey, T. O. Videen, J. Wu, J. W. M. Usche, F. J. Revilla, J. M. Hartlein, A. R. Wernle, et al.
Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease
Brain, October 1, 2008; 131(10): 2710 - 2719.
[Abstract] [Full Text] [PDF]


Home page
JSLHRHome page
C. L. Ludlow, J. Hoit, R. Kent, L. O. Ramig, R. Shrivastav, E. Strand, K. Yorkston, and C. M. Sapienza
Translating Principles of Neural Plasticity Into Research on Speech Motor Control Recovery and Rehabilitation
J Speech Lang Hear Res, February 1, 2008; 51(1): S240 - S258.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Feigin, M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan, M. J. During, and D. Eidelberg
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
PNAS, December 4, 2007; 104(49): 19559 - 19564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.